Core Viewpoint - The approval of D-alloheptulose as a new food ingredient in China is expected to invigorate the domestic sugar substitute market, which is already competitive with existing substitutes like erythritol and aspartame [2][14]. Industry Overview - The global production capacity of D-alloheptulose is concentrated in the US, Japan, and South Korea, with the top five companies holding approximately 70% of the market share [4][5]. - The global market for D-alloheptulose has grown from $0.33 billion in 2019 to $1.73 billion in 2023, with a compound annual growth rate (CAGR) of 33.26%, and is projected to reach $5.45 billion by 2030 [13]. Market Dynamics - The approval of D-alloheptulose is part of a broader trend where more sugar substitutes are being allowed in the food industry, leading to new product formulations that cater to consumer demand for low-sugar options [3][16]. - The competition in the sugar substitute market is intensifying, with erythritol being a widely used natural sweetener, and D-alloheptulose presenting a potential opportunity for differentiation due to its unique properties [14][15]. Production and Technology - D-alloheptulose is primarily produced through microbial fermentation and enzyme conversion methods, which have their own advantages and challenges [8][9]. - Domestic production of D-alloheptulose faces technical barriers, particularly in enzyme performance and crystallization processes, which are critical for efficient production [9][10]. Competitive Landscape - Established companies with a long history in the D-alloheptulose market have a competitive edge over new entrants due to their technological expertise and established customer relationships [12]. - The regulatory environment for D-alloheptulose production is stringent, requiring extensive safety evaluations and approvals, which can delay market entry for new producers [12]. Application Potential - D-alloheptulose has versatile applications across food, pharmaceuticals, and dietary supplements, with its ability to enhance flavor and improve product characteristics in various formulations [6][8]. - The growing consumer awareness of health and wellness is driving demand for low-calorie sweeteners, positioning D-alloheptulose favorably in the market [16].

Summary of Key Points from the Conference Call Industry Overview - The approval of allulose as a new food ingredient expands its application in the food sector, particularly in weight loss and diabetes-related products, and allows for food thermal processing, although production methods have specific strain and donor limitations [1][4][16]. Company Insights COFCO Technology - COFCO Technology has developed allulose production technology using corn starch and has received approval for related enzyme preparations, advancing the construction of a production line with a capacity of 10,000 tons. Expected net profits for 2025-2027 are projected at 100 million, 160 million, and 230 million yuan respectively, with a year-on-year growth rate of approximately 300% this year [1][5]. Bailingbao - Bailingbao is a leading company in functional metabolic products, with a production capacity exceeding 5,000 tons and plans to expand to 30,000 tons by 2026. The company is primarily focused on exports [1][7]. Bailing Chuangyuan - Bailing Chuangyuan is the first company in China to achieve industrial-scale production and revenue from allulose, with a projected revenue of 156 million yuan in 2024 and a gross margin of 19%. The company plans to expand capacity in Thailand, primarily for export [1][6][17]. Jinhui Industrial - Jinhui Industrial is a leader in the sugar substitute industry, with a leading global market share in sucralose and acesulfame. The company is actively developing allulose and offers blended sweetness solutions [3][13]. Jindawei - Jindawei is constructing a 30,000-ton allulose project, benefiting from the approval of allulose as a food additive. The company has also acquired the US brand RX Sugar to expand its portfolio [22]. Market Dynamics - Allulose is viewed as a potential substitute for sucrose, with a sweetness level of 70% compared to sucrose but only 1/10th the calories. It has health benefits such as vascular softening and blood sugar regulation, making it suitable for weight loss and diabetes applications [2][16]. - The global sugar substitute market is still in its early stages, with only about 10% of global food consumption utilizing sugar substitutes. The market for sugar substitutes is expected to grow significantly [9]. Competitive Landscape - Allulose's approval is a significant event for the sugar substitute industry, marking a new phase of development. Companies with technological and production capacity reserves, such as Bailing Chuangyuan, Bailingbao, and COFCO Technology, are expected to have favorable market prospects [8][16]. - The competitive advantage of allulose includes its low caloric content, low glycemic index, and ability to participate in the Maillard reaction, which enhances its application in baked goods [12][16]. Financial Projections - Bailing Chuangyuan's profit growth exceeded expectations at 52% in Q1 2025, with projected annual revenue and profit growth rates of over 35% and 43% respectively [3][19]. - COFCO Technology's stock price is worth monitoring, with a target price of 6.8 yuan, reflecting a projected year-on-year growth of approximately 300% [1][8]. Conclusion - The approval of allulose as a new food ingredient is expected to stimulate capacity release and expand market opportunities for companies with established production capabilities. The overall outlook for the sugar substitute industry remains positive, with significant growth potential in various food applications [1][8][16].